Expansion Therapeutics logo

Expansion Therapeutics

Bringing transformative therapies to patients with severe RNA-mediated diseases.

29 employees · est. 2016 · Jupiter, United States

VS
Saverna Therapeutics AG logo

Saverna Therapeutics AG

Saverna Therapeutics aims to discover highly active, selective and cell-permeable molecules to target RNA biology

4 employees · est. 2017 · Allschwil, Switzerland

Expansion Therapeutics is the older company (2016 vs 2017); Expansion Therapeutics is the larger of the two.

Side-by-Side Comparison

Expansion Therapeutics Saverna Therapeutics AG
Founded
2016 older 2017
Headquarters
Jupiter, United States Allschwil, Switzerland
Employees
29 larger 4
Industry
Biotechnology, Health Care, Health and Wellness AI, Health and Wellness
Funding Stage
Series Unknown Series Unknown
Total Funding
$142.22M Not tracked yet
Funding Rounds
3 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
RNA-mediated Diseases, Drug Discovery, Small Molecule Medicines, Expansion Repeat Diseases, Therapeutics, Jupiter, Florida, Intellectual Property, RNA-targeted Drug Candidates, Potent Small Molecule Binders, Biopharmaceutical, Precision Medicine, Therapeutic Development, Biomedical Research, Drug Development Pharmaceutical Industry, Drug Discovery, Small Molecule Drugs, Non-coding RNA, Swiss Start-up, Disease Treatment, RNA-targeting Compounds, Inflammation, Cancer Research, Infection Treatment, Biomedical Research, Precision Medicine, Therapeutics Development
Website
expansionrx.com saverna.com
Expansion Therapeutics logo

About Expansion Therapeutics

Expansion Therapeutics, founded in 2016, is a biotechnology and healthcare startup based in United States. The company's mission as stated in their slogan, "Bringing transformative therapies to patients with severe RNA-mediated diseases," is to develop small molecule medicines for RNA-mediated disea...

Saverna Therapeutics AG logo

About Saverna Therapeutics AG

Saverna Therapeutics is a Swiss pharmaceutical start-up company founded in 2017 with the focus on developing small molecule drugs to target non-coding RNA for treating diseases with high unmet need. Founded by four former lab heads at Novartis, Switzerland, the company aims to leverage their experti...

We will tell you when either one moves

BounceWatch watches Expansion Therapeutics and Saverna Therapeutics AG for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Expansion Therapeutics and Saverna Therapeutics A... — by email.

Frequently Asked Questions

Expansion Therapeutics — Bringing transformative therapies to patients with severe RNA-mediated diseases.. Saverna Therapeutics AG — Saverna Therapeutics aims to discover highly active, selective and cell-permeable molecules to target RNA biology. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Expansion Therapeutics has raised $142.22M while Saverna Therapeutics AG has raised undisclosed funding.
Expansion Therapeutics and Saverna Therapeutics AG operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Expansion Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Expansion Therapeutics on 13 Sep 2024, and Saverna Therapeutics AG on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes